Wellgistics Health, Inc. (WGRX): debt financing — Wellgistics Health issues $1.25M in promissory notes at 20% discount to accredited investors

Wellgistics Health, Inc.

Company entered Note Purchase Agreement for up to $1,250,000 aggregate principal; purchase price $1,000,000 (20% OID).
Notes mature in 12 months or upon next Qualified Financing (equity offering); bear 0% interest (15% default rate).
Investors get participation rights in future offerings for at least one year or while notes outstanding.
Company restricted from incurring additional debt or granting liens while notes outstanding.
Offering exempt from registration under Section 4(a)(2) and Rule 506(b); accredited investors only.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Wellgistics Health, Inc. incurred senior notes of up to $1,250,000 in aggregate principal amount with certain investors at 0% maturing the twelve (12) month anniversary of the date of issuance of the Notes, or (b) the date of closing of the next issuance and sale of capital stock of the Company.

Instrument: senior notes
Principal: up to $1,250,000 in aggregate principal amount
Counterparty: certain investors
Rate: 0%
Maturity: the twelve (12) month anniversary of the date of issuance of the Notes, or (b) the date of closing of the next issuance and sale of capital stock of the Company
Event: incurrence

Exact text from the filing

the Company agreed to issue and sell to the Investors in a private offering up to $1,250,000 in aggregate principal amount (the “Aggregate Principal Amount”) of promissory notes (the “Notes”) (the “Offering”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. entered into Note Purchase Agreement with certain investors valued at up to $1,250,000 in aggregate principal amount (effective 2026-04-01).

Action: entry
Agreement: notes offering
Counterparty: certain investors
Value: up to $1,250,000 in aggregate principal amount
Effective: 2026-04-01

Exact text from the filing

On April 1, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $1,250,000 in aggregate principal amount (the “Aggregate Principal Amount”) of promissory notes (the “Notes”) (the “Offering”).

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-015548

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.